Abstract
“The 1st Turkish in vitro Diagnostic Symposium” was organized in İzmir between the dates 18–20 February 2016 with cooperation of Turkish Biochemistry Society Izmir Branch and Dokuz Eylul University Institute of Health Sciences. This article presents a collection of the subjects, recommendations and results included in the final report of the symposium. Symposium subjects were analysed under separate titles and evaluated together with results obtained from various reports on medical devices (MD) in the last decade. According to the final report, the subjects to be considered on preferential basis include “configuration of the websites of legal authorities, standardization and accreditation institutions in a way to access work on in vitro Diagnostic (IVD)”, “activation of university-industry cooperation”, “determination of national standards parallel to international standards” and “carrying out the statistics about IVD-MD in Turkey as immediate as possible”. Drawing attention to the fact that there is a requirement for competent man power for every-stage of IVD-MD lifecycle, it is recommended that postgraduate education programmes are founded to serve these fields. Consequently, this symposium enabled to determine the basic problems about the sector by bringing together the stakeholders related to IVD-MD field and to come up with an action plan in accordance with the recommendations.
Özet
“1. Türkiye in vitro Diyagnostik Sempozyumu’ Türk Biyokimya Derneği İzmir Şubesi ve Dokuz Eylül Üniversitesi Sağlık Bilimleri Enstitüsü işbirliği ile 18–20 Şubat 2016 tarihlerinde İzmir’de düzenlenmiştir. Bu makalede sempozyum sonuç raporunda yer alan konular, öneriler ve sonuçlar derlenerek sunulmuştur. Sempozyum konuları; ayrı başlıklar altında incelenmiş ve son 10 yılda tıbbi cihazlarla ilgili çeşitli raporlardan elde edilen sonuçlarla birlikte değerlendirilmiştir. Sonuç raporuna göre; “yasal otoritelerin, standardizasyon ve akreditasyon kurumlarının web sitelerinin IVD alanındaki çalışmalara erişilecek şekilde yapılandırılması”, “üniversite-sanayi işbirliğinin etkinleştirilmesi”, “uluslararası standartlara paralel olarak ulusal standartların belirlenmesi”, “Türkiye'deki IVD TC ile ilgili istatistiklerin bir an önce gerçekleştirilmesi” öncelikle ele alınacak konular olarak belirlenmiştir. IVD TC yaşam döngüsünün her aşaması için yetkin insan kaynağına gereksinim bulunduğuna dikkat çekilerek, bu alanlara yönelik lisansüstü eğitim programlarının açılması önerilmiştir. Ayrıca, üniversitelerin meslek yüksekokullarında “teknolog” gibi ara eleman yetiştiren programların yapılandırılması gerektiği vurgulanmıştır. Sonuç olarak bu sempozyum; IVD TC alanıyla ilgili paydaşları bir araya getirerek sektörle ilgili temel sorunların saptanmasını ve öneriler doğrultusunda bir eylem planı oluşturulmasını sağlamıştır.
Introduction
All instruments, reagents and related accessories used for research, clinical diagnosis, follow-up and treatment are called “in vitro diagnostic medical device (IVD-MD)”. Based on the fact that more than 70% of the patients consulting hospitals go through medical laboratory tests and 85%–90% of these tests are imported in Turkey, “The 1st Turkish in vitro diagnostic symposium” was organized in İzmir on 18–20 February 2016 with 120 participants and with the cooperation of Turkish Biochemistry Society İzmir Branch and Dokuz Eylul University Institute of Health Sciences to determine the definition and scope of IVD-MD, discuss current applications reviewing the role of all stakeholders in terms of production and innovation, generating recommendations for national policies and strategies related to the subject and prepare an action plan to create an interactive online IVD platform. The sessions, stakeholders and speakers at the symposium were determined according to two main sections in IVD-MD lifecycle, namely preproduction and postproduction (Figure 1).

IVD MD lifecycle.
Current status and recommendations on legal authority and compliance evaluation
When an online search is carried out with the keywords “IVD”, “in vitro” or “extracorporeal”, there is no access to the applications in Turkey. This indicates that the websites of the legal authorities as well as standardization & accreditation institutions are not configured to access the work in this field [1]. In nomenclature, the conformity of logical observation identifiers names and codes (LOINC) match-ups in Turkey with the test codes in LOINC international should be evaluated and results should be published on the relevant websites [2]. MD National information bank (TITUBB) created by Turkish Pharmaceuticals and MD Agency is a significant database for medical device records based on the Global medical device nomenclature (GMDN) and United Nations product and services code (UNPSC). The efficiency of these international codes used in TITUBB as well as the related nomenclature and explanations for IVD-MD should be evaluated and announced. The work in the Ministry of Health (MoH) should be carried out with a holistic perspective and coordination of related agencies and implemented parallel to the applications in the world.
Turkish standardization institute (TSE) should prepare and publish educational video presentations and standards for IVD-MD so they are easily accessible from the website.
Current status and recommendations on IVD-MD lifecycle
The cooperation between universities and industry should be at sufficient and efficient level. Necessary information should be provided and the access should be facilitated for the industrialists for them to take adequate advantage of the endorsement provided by the governmental institutions. “Material resources management systems” agencies should be founded in all public and private institutions to carry out the statistics about IVD-MD in Turkey. National standards in accordance with international standards should be determined.
In IVD product lifecycle, although both idea improvement and project production are at a promising level and public support is various and sufficient at R&D level, there is an obstruction in validation and quality-risk management levels following the prototype production. The main reasons are lack of knowledge, problems related to project management and insufficient support for the production. Thus, even though technological advancements are followed and innovative ideas are improved, there is no continuity and ideas cannot be transformed into production. An example to this are the problems resulting both from the applications of the MoH and Public Procurement Law in producing diagnostic kits. Thus, support and training from legal authorities are needed [3, 4].
There is need for legal regulations for the encouragement and maintenance of domestic production and the use of domestic products. Establishing and extending “Health Free Zones” is necessary and important to support domestic producers. It would also be appropriate to include IVD-MD issues in “Quality and Efficiency in Health” meetings held by the Ministry of Science, Industry and Technology, and in “Quality in Public” meetings organised by Turkish Quality Association (Kal-Der) [5].
Current status and recommendations on education-training, professional titles and staff
As observed in lifecycle table, there is need for qualified staff in all levels. The only staff assured to work in medical laboratories using IVD-MDs and in laboratories of Medical Schools are those who hold a diploma from the MoH and are medical technicians. There are legal regulations against employing staff graduated from other fields. There should be programmes at vocational schools of universities to train intermediate staff such as technologist. It is important to open and extend graduate programmes related to the field of IVD-MD so as to train expert and qualified work power in laboratory medicine. In-service training activities for the technicians, operators of the state institutions and organisations should be supported by related expertise associations as well as the participation of the MoH and others.
Current status and recommendations on research, development and innovation
The number of people aiming at product development is insufficient. Lack of university-industry cooperation results in not transforming the discoveries into products. Although there is a law (6556) related to supporting research in medical technologies, there are some obstacles in implementation. Restrictions of research-development cooperation in terms of Techno-park and R&D Centres hinder the improvements.
Despite the difficulties mentioned above, it is obvious that there is a real space for the entrepreneurs in the field of medical technologies. Such an attempt can be achieved through state support.
Insufficiency in innovation management is another issue. The Turkish innovation index is 58 in the global scale [6].
Structuring graduate programmes on IVD-MD fields will enable the development of innovative ideas requiring high level of information and equipment as well as ideas possible to put into practice only through multidisciplinary contributions [7].
Current status and recommendations on quality assurance
The requirement to comply with total quality principles, make use of quality instruments and conform to the plan-do-check-act cycle in all applications is emphasized [8].
Overall evaluation
The symposium ensured the gathering of stakeholders of IVD-MD and fundamental problems in the field are highlighted within the context of target outputs of the symposium.
It is decided that an interactive online IVD-MD portal is urgently generated to serve to determine national IVD policy and strategy and ensure the continuous and systematic approach to this subject.
Conflict of interest: The authors declare no conflict of interests.
References
1. Available at: http://www.gmp-compliance.org/guidemgr/files/IVD_DIRECTIVE.PDF. Accessed: 20 Dec 2016.Search in Google Scholar
2. McDonald CJ, Huff SM, Suico JG, Hill G, Leavelle D, Aller R, et al. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin Chem 2003;49:624–33.10.1373/49.4.624Search in Google Scholar
3. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/IVDRegulatoryAssistance/ucm123682.htm. Accessed: 20 Dec 2016.Search in Google Scholar
4. Mansfield E, O’Leary TJ, Gutman SI. Food and drug administration regulation of in vitro diagnostic devices. J Mol Diagn 2005;7:2–7.10.1016/S1525-1578(10)60002-5Search in Google Scholar
5. Technology Development Foundation of Turkey (TDFT). Kiper M. (Edt.) Medical Device Sector and Strategy Advice in the World and Turkey, Concepts in the World, Case in the World, Case in Turkey, Analysis and Strategy. Ankara. 2013. Available at: http://www.ideaport.org.tr/uploads/read/file/tibbi-cihaz-sektoerue-ve-strateji-oenerisi-2013-16.pdf. Accessed: 20 Dec 2016.Search in Google Scholar
6. Dutta S, Lanvin B, Wunsch-Vincent S. The Global Innovation Index 2015 Effective Innovation Policies for Development, 2015:16.Search in Google Scholar
7. Ankara Development Agency, Development Bank of Turkey. Ankara Medical Devices Sector Analysis.Ankara 2013. Available at: http://www.ankaraka.org.tr/tr/files/TIBB%C4%B0%20C%C4%B0HAZ%20ANAL%C4%B0Z%C4%B0.pdf. Accessed: 20 Dec 2016.Search in Google Scholar
8. T.C. Ministry of Development, Medical Equipment and Medical Supplies Working Group Report. Ankara 2014. Available at: http://www.seis.org.tr/docs/daha-cok-uretmeliyiz/kalkinma-plani/tibbi-cihaz-ve-tibbi-malzeme-calisma-grubu-raporu.pdf. Accessed: 20 Dec 2016.Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Article
- Automation in the clinical laboratory: integration of several analytical and intralaboratory pre- and post-analytical systems
- Research Articles
- Flow cytometric detection of endothelial progenitor cells (EPC) in acute coronary syndrome
- Evaluation of prolidase activity in uremic bone disease
- The independent relationship between hemoglobin A1c and homeostasis model assessment of insulin resistance in non-diabetic subjects
- Association of missense substitution of A49T and V89L in the SRD5A2 gene with prostate cancer in Turkish patients
- Delays in reporting critical values from clinical laboratories to responsible healthcare staff
- Re-determining the cut-off points of FIB-4 for patients monoinfected with chronic hepatitis B virus infection
- Approach to pre-analytical errors in a public health laboratory
- Serum proPSA as a marker for reducing repeated prostate biopsy numbers
- NT-proBNP levels in β-thalassemia major patients without cardiac hemosiderosis
- Comparison of high sensitive and conventional troponin assays in diagnosis of acute myocardial infarction
- Assessment of macroprolactinemia rate in a training and research hospital from Turkey
- Opinion Papers
- Evaluation of the first Turkish in vitro diagnostic symposium
- The report of the 1st Turkey in vitro diagnostic symposium results
- Venous blood gases: is it useful in COPD?
- Letter to the Editor
- How are ethical issues in the laboratory medicine held in Turkey? A perspective view through medical ethics and clinical laboratory science
Articles in the same Issue
- Frontmatter
- Review Article
- Automation in the clinical laboratory: integration of several analytical and intralaboratory pre- and post-analytical systems
- Research Articles
- Flow cytometric detection of endothelial progenitor cells (EPC) in acute coronary syndrome
- Evaluation of prolidase activity in uremic bone disease
- The independent relationship between hemoglobin A1c and homeostasis model assessment of insulin resistance in non-diabetic subjects
- Association of missense substitution of A49T and V89L in the SRD5A2 gene with prostate cancer in Turkish patients
- Delays in reporting critical values from clinical laboratories to responsible healthcare staff
- Re-determining the cut-off points of FIB-4 for patients monoinfected with chronic hepatitis B virus infection
- Approach to pre-analytical errors in a public health laboratory
- Serum proPSA as a marker for reducing repeated prostate biopsy numbers
- NT-proBNP levels in β-thalassemia major patients without cardiac hemosiderosis
- Comparison of high sensitive and conventional troponin assays in diagnosis of acute myocardial infarction
- Assessment of macroprolactinemia rate in a training and research hospital from Turkey
- Opinion Papers
- Evaluation of the first Turkish in vitro diagnostic symposium
- The report of the 1st Turkey in vitro diagnostic symposium results
- Venous blood gases: is it useful in COPD?
- Letter to the Editor
- How are ethical issues in the laboratory medicine held in Turkey? A perspective view through medical ethics and clinical laboratory science